Exploring Ferroptosis Biology
The Henry lab focuses on ferroptosis, an iron-dependent form of cell death, and its profound implications in normal physiology and pathological conditions such as cancer and liver disease. We employ an integrative approach in our research. This includes functional genomic screens, metabolomics, bioengineering, and biochemical methodologies, as well as a range of in vitro and in vivo models. We are committed to pushing the boundaries of knowledge in this domain, fostering interdisciplinary collaborations, and translating our discoveries to inform new therapies.
Featured News
-
Fri, Sep 13, 2024
Dr Henry has been awarded an MIT Stem Cell Initiative pilot grant to support her research on ferroptosis in metabolic-associated steatotic liver disease. -
Mon, Apr 8, 2024
Kandice Levental and Whitney Henry coauthored an article titled “Lipidomes define immune cell identity” discussing a study which showed that cell-specific lipid compositions determine a key functional phenotype: their susceptibility to ferroptosis. -
Mon, Dec 4, 2023
Whitney Henry receives a grant from the Emerald Foundation, Inc. for groundbreaking cancer research. This funding marks the first installment of a three-year commitment to support the lab's pioneering project, Ferroptosis and the Tumor Immune Microenvironment. -
Wed, Sep 20, 2023
For the first Ferroptosis France Symposium in January 2024, the state of the art in Ferroptosis will be presented by world leaders to feature the latest innovations and future trends in this innovative and dynamic field.